Arrowhead Pharmaceuticals Inc. (ARWR) Reports Q3 Loss of $0.96
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $81.82 +0.96%
Revenue Growth %: +89.5%
Financial Fact:
Salaries: 4.11M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Revenue Growth %: +89.5%
Financial Fact:
Salaries: 4.11M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($0.96), versus ($0.68) reported last year. Revenue for the quarter came in at $15.8 million, versus $32.4 million reported last year.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
- Pfizer reafffirms 2026 guidance after CFO transition announcement
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
